CareDx, Inc.
For the period ended Dec 31, 2025. Filed Feb 25, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 25, 2026
CDNA$84.42+7.5%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets
(In thousands, except share data)
| As of December 31, | ||
|---|---|---|
| 2025 | 2024 | |
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $65,429 | $114,689 |
| Marketable securities | 111,779 | 145,964 |
| Accounts receivable | 42,628 | 64,605 |
| Inventory | 26,705 | 19,503 |
| Prepaid and other current assets | 10,591 | 7,071 |
| Total current assets | 257,132 | 351,832 |
| Property and equipment, net | 32,971 | 33,552 |
| Operating lease right-of-use assets | 22,760 | 24,340 |
| Marketable securities, non-current | 24,165 | — |
| Intangible assets, net | 31,960 | 38,184 |
| Goodwill | 40,336 | 40,336 |
| Restricted cash | 551 | 585 |
| Other assets | 3,353 | 2,221 |
| Total assets | $413,228 | $491,050 |
| Liabilities and stockholders’ equity | ||
| Current liabilities: | ||
| Accounts payable | $9,988 | $7,686 |
| Accrued compensation | 38,107 | 38,333 |
| Accrued and other liabilities | 41,754 | 43,352 |
| Total current liabilities | 89,849 | 89,371 |
| Deferred tax liability | 181 | 164 |
| Contingent consideration | 161 | 174 |
| Operating lease liabilities, less current portion | 19,679 | 22,263 |
| Other liabilities | 257 | 645 |
| Total liabilities | 110,127 | 112,617 |
| Commitments and contingencies (Note 8) | ||
| Stockholders’ equity: | ||
| Preferred stock: $0.001 par value; 10,000,000 shares authorized at December 31, 2025 and 2024; no shares issued and outstanding at December 31, 2025 and 2024 | — | — |
| Common stock: $0.001 par value; 100,000,000 shares authorized at December 31, 2025 and 2024; 50,916,644 shares issued and outstanding at December 31, 2025; 54,771,203 shares issued and outstanding at December 31, 2024 | 50 | 51 |
| Additional paid-in capital | 1,043,925 | 1,013,193 |
| Accumulated other comprehensive loss | (5,515) | (8,569) |
| Accumulated deficit | (735,359) | (626,242) |
| Total stockholders’ equity | 303,101 | 378,433 |
| Total liabilities and stockholders’ equity | $413,228 | $491,050 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.